MARSHALL WACE, LLP - HEALTH CATALYST INC ownership

HEALTH CATALYST INC's ticker is and the CUSIP is 42225TAB3. A total of 21 filers reported holding HEALTH CATALYST INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of HEALTH CATALYST INC
ValueSharesWeighting
Q2 2023$19,133,999
-12.3%
20,000,000
-16.7%
0.04%
-19.6%
Q1 2023$21,828,001
+11.3%
24,000,000
+6.7%
0.05%
+4.5%
Q4 2022$19,604,251
+8.0%
22,500,000
+5.6%
0.04%
+10.0%
Q3 2022$18,147,000
+22.4%
21,300,000
+29.1%
0.04%
+33.3%
Q2 2022$14,824,000
-21.8%
16,500,0000.0%0.03%
-16.7%
Q1 2022$18,947,000
-21.3%
16,500,0000.0%0.04%
-18.2%
Q4 2021$24,080,000
+96.1%
16,500,000
+135.7%
0.04%
-13.7%
Q3 2021$12,277,000
-8.6%
7,000,0000.0%0.05%
-16.4%
Q2 2021$13,437,0007,000,0000.06%
Other shareholders
HEALTH CATALYST INC shareholders Q2 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 19,626$18,6651.50%
Opti Capital Management, LP 20,759,000$19,8521.43%
TENOR CAPITAL MANAGEMENT Co., L.P. 43,591,000$42,102,8520.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 30,000,000$28,517,1300.63%
LINDEN ADVISORS LP 60,490,000$57,628,9460.59%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 13,661,000$13,012,1030.54%
PIER 88 INVESTMENT PARTNERS LLC 1,490,000$1,433,2310.36%
Kohlberg Kravis Roberts & Co. L.P. 1,770,000$1,702,5630.06%
LAZARD ASSET MANAGEMENT LLC 32,556,000$31,3150.04%
PRELUDE CAPITAL MANAGEMENT, LLC 430,000$413,6170.03%
View complete list of HEALTH CATALYST INC shareholders